Related Experiment Video
Updated: Jan 22, 2026

Author Spotlight: A Computational Pipeline for Analyzing Chimeric Noncoding RNA-Target RNA Interactions in High-Throughput Sequencing Data
Published on: December 1, 2023
Long noncoding RNA DDX11-AS1 induced by YY1 accelerates colorectal cancer progression through targeting miR-873/CLDN7
1Department of General Surgery, the Frist Medical Centre of Chinese of General Hospital, Haidian, Beijing, China. tianjingbo1226@126.com.
Objective:
Increasing studies have confirmed long non-coding RNAs (lncRNAs) as novel regulators in tumorigenesis. LncRNA DDX11 antisense RNA 1 (DDX11-AS1) has been found to be abnormally expressed in several tumors. In this work, we aimed to evaluate its expressions and functions in colorectal cancer (CRC).
Patients And Methods:
The Cancer Genome Atlas (TCGA) datasets were used for the identification of dysregulated lncRNA in CRC. The levels of DDX11-AS1 were determined in tumor tissues and cell lines by Real Time-Polymerase Chain Reaction (RT-PCR). The clinical significance of DDX11-AS1 in CRC patients was analyzed using Chi-square test and Kaplan-Meier analysis. Functional assays for the exploration of DDX11-AS1 and miR-873 were performed using a series of cells experiment. ChIP assay and luciferase reporter assays were used to explore the mechanism of actions of DDX11-AS1 in CRC cells.
Results:
We identified DDX11-AS1 as a new CRC-related lncRNA whose levels were distinctly up-regulated in CRC specimens and cell lines, partly induced by YY1. Clinical explorations suggested that increased expressions of DDX11-AS1 in CRC were positively associated with lymph nodes metastasis and TNM stage and had a distinct influence on the overall survival. Further multivariate assays indicated that DDX11-AS1 was an independent prognostic parameter implying a poorer clinical outcome for patients with CRC. Functional assays revealed that the knockdown of DDX11-AS1 suppressed the proliferation, migration, and invasion of CRC cells, and stimulate apoptosis. Mechanistic studies showed that the up-regulation of DDX11-AS1 competitively bound to miR-873 prevented CLDN7 from miRNAs-mediated degradations, thus facilitated the CRC progress. Further rescue assays were carried out to achieve confirmation.
Conclusions:
Our present findings may enhance our understanding of the pathogenesis of CRC and revealed DDX11-AS11 as a potential therapeutic target for CRC.
Insights
Long non-coding RNA DDX11-AS1 is upregulated in colorectal cancer (CRC), promoting tumor growth and metastasis. Targeting DDX11-AS1 may offer a new therapeutic strategy for CRC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are increasingly recognized as key regulators in cancer development.
- LncRNA DDX11 antisense RNA 1 (DDX11-AS1) has shown aberrant expression in various tumors, prompting investigation in colorectal cancer (CRC).
Purpose of the Study:
- To investigate the expression patterns and functional roles of lncRNA DDX11-AS1 in colorectal cancer (CRC).
- To explore DDX11-AS1 as a potential diagnostic and therapeutic target for CRC.
Main Methods:
- Utilized The Cancer Genome Atlas (TCGA) datasets for lncRNA identification in CRC.
- Quantified DDX11-AS1 expression in CRC tissues and cell lines using Real Time-Polymerase Chain Reaction (RT-PCR).
- Performed clinical significance analysis (Chi-square, Kaplan-Meier), functional assays, ChIP, and luciferase reporter assays to elucidate mechanisms.
Main Results:
- DDX11-AS1 was significantly upregulated in CRC specimens and cell lines, partly induced by YY1.
- Elevated DDX11-AS1 expression correlated with lymph node metastasis, advanced TNM stage, and poorer overall survival in CRC patients.
- Knockdown of DDX11-AS1 inhibited CRC cell proliferation, migration, and invasion, while promoting apoptosis.
- Mechanistically, DDX11-AS1 sponges miR-873, preventing CLDN7 degradation and facilitating CRC progression.
Conclusions:
- DDX11-AS1 is a novel, independent prognostic biomarker for colorectal cancer.
- The findings highlight DDX11-AS1 as a potential therapeutic target for improving CRC treatment outcomes.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Hypothalamic-Pituitary Axis
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Perpendicular-Axis Theorem
Consider a circular disc of mass M and radius R lying along an x-y plane. The origin lies at the center of the disc, and the z-axis is perpendicular to the disc's plane. All three axes coincide at the disc's center. The moment of inertia of this...
Parallel-axis Theorem

